Text Size
3039 studies found for:    "Depressive Disorder" [DISEASE]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed The Effects of Bupropion on Residual and Cognitive Symptoms in SSRI-treated Depression
Conditions: Depression;   Major Depressive Disorder;   Unipolar Depression
Intervention: Drug: bupropion
22 Recruiting Buprenorphine for Treatment Resistant Depression
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Buprenorphine;   Drug: Placebo
23 Active, not recruiting Insulin Resistance in Patients With Major Depression
Conditions: Depression;   Bipolar Disorder;   Mood Disorders;   Insulin Resistance;   Depressive Disorder, Major;   Depressive Disorder
Intervention:
24 Terminated Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder
Interventions: Device: Cortical Stimulation;   Device: Sham
25 Completed Major Depressive Disorder In The Elderly
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: bupropion XL
26 Completed
Has Results 		Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine succinate sustained-release (DVS SR);   Drug: Escitalopram
27 Unknown † Using Neuroimaging to Investigate Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression;   Anxiety
Intervention:
28 Completed A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD)
Intervention: Drug: GSK372475
29 Recruiting Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Biological: RO4995819
30 Completed
Has Results 		Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR);   Drug: Placebo
31 Completed Depression Study In Elderly Patients
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: Paroxetine CR
32 Completed A Study of Infliximab for Treatment Resistant Major Depression
Conditions: Depression;   Depression Bipolar I;   Depression Bipolar II
Interventions: Drug: infliximab (remicade);   Drug: Infliximab
33 Completed
Has Results 		A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
34 Completed
Has Results 		A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
35 Completed
Has Results 		A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   MDD;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
36 Completed
Has Results 		Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Drug: Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
37 Completed
Has Results 		A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
38 Recruiting Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
Conditions: Bipolar Disorder;   Bipolar Depression;   Bipolar I Depression;   Bipolar II Depression
Intervention: Drug: Minocycline
39 Recruiting Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
Conditions: Depressive Disorder, Major;   Depressive Disorder, Minor;   Dysthymic Disorder
Interventions: Other: RESPECT-D;   Other: RESPECT-D-E (Enhanced)
40 Completed
Has Results 		Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD)
Interventions: Drug: paroxetine IR 10mg tablet;   Drug: paroxetine IR 20mg tablet;   Drug: matched placebo to paroxetine IR 10mg or 20mg;   Drug: Paroxetine CR 12.5mg tablet;   Drug: Paroxetine CR 25mg tablet;   Drug: matched placebo to paroxetine CR 12.5mg or 25mg
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years